Rani Therapeutics Holdings annual return on equity
2022
2023
2024
2025
Rani Therapeutics Holdings Return on Equity (ROE) Growth & History (RANI)
Rani Therapeutics Holdings's return on equity was −169.55% for fiscal 2025.
View full Rani Therapeutics Holdings company overviewRani Therapeutics Holdings annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −169.55% | +234.51 pp |
| 2024 | 2024-12-31 | −404.07% | −267.42 pp |
| 2023 | 2023-12-31 | −136.64% | −64.04 pp |
| 2022 | 2022-12-31 | −72.60% | — |
Rani Therapeutics Holdings quarterly return on equity
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −21.85% | — |
| Q1 2026 | 2026-03-31 | −22.90% | — |
| Q4 2025 | 2025-12-31 | −81.95% | +268.09 pp |
| Q4 2024 | 2024-12-31 | −350.04% | −303.37 pp |
| Q3 2024 | 2024-09-30 | −227.81% | −183.64 pp |
| Q2 2024 | 2024-06-30 | −133.00% | −99.06 pp |
| Q1 2024 | 2024-03-31 | −73.86% | −49.08 pp |
| Q4 2023 | 2023-12-31 | −46.67% | −24.44 pp |
| Q3 2023 | 2023-09-30 | −44.17% | −26.49 pp |
| Q2 2023 | 2023-06-30 | −33.94% | −18.88 pp |
| Q1 2023 | 2023-03-31 | −24.78% | −12.43 pp |
| Q4 2022 | 2022-12-31 | −22.23% | −34.16 pp |
| Q3 2022 | 2022-09-30 | −17.68% | — |
| Q2 2022 | 2022-06-30 | −15.07% | — |
| Q1 2022 | 2022-03-31 | −12.35% | — |
| Q4 2021 | 2021-12-31 | 11.93% | — |
Rani Therapeutics Holdings return on equity trends
Between the periods ended 2022-12-31 and 2025-12-31, Rani Therapeutics Holdings's return on equity decreased from −72.60% to −169.55%, a change of −96.95 percentage points. The latest reported quarter, Q2 2026, shows −21.85%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Rani Therapeutics Holdings source filings ↗